Oncologie

Le groupe Eurobio Scientific a finalisé avec succès l'acquisition de Quimark SRL

As of March 1st, 2025, Eurobio Scientific Group has successfully completed the acquisition of Quimark SRL, our trusted distributor of 𝐄𝐧𝐝𝐨𝐏𝐫𝐞𝐝𝐢𝐜𝐭® and 𝐏𝐫𝐨𝐥𝐚𝐫𝐢𝐬® in Italy. This strategic step strengthens our presence in the Italian market and reaffirms our commitment to providing innovative oncology solutions to patients and healthcare professionals. We look forward to this new […]

Le groupe Eurobio Scientific a finalisé avec succès l'acquisition de Quimark SRL Lire plus "

Eurobio Scientific élargit son portefeuille de produits d'oncologie grâce à un partenariat avec Biovica

Eurobio Scientific has signed a strategic agreement with Biovica, a company specializing in cancer monitoring, to distribute DiviTum® TKa in key European markets, including DACH, UK, FR and Benelux. This collaboration covers 60% of the European market potential and strengthens Eurobio Scientific’s oncology diagnostics offering. DiviTum® TKa is a blood-based biomarker test that monitors and predicts

Eurobio Scientific élargit son portefeuille de produits d'oncologie grâce à un partenariat avec Biovica Lire plus "

Retour en haut
(function () { function activateTabFromHash() { var hash = window.location.hash; if (!hash) return; var tabTitle = document.getElementById(hash.substring(1)); if (!tabTitle) return; if (!tabTitle.classList.contains("elementor-tab-title")) return; // Use Elementor's own click handler tabTitle.click(); } // Wait for Elementor frontend to be ready window.addEventListener("elementor/frontend/init", function () { setTimeout(function () { activateTabFromHash(); }, 300); }); // Also handle hash change (menu clicks) window.addEventListener("hashchange", function () { setTimeout(function () { activateTabFromHash(); }, 100); }); })();